Alliance Global Partners Begins Coverage on Evogene (NASDAQ:EVGN)

Alliance Global Partners assumed coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $1.85 price objective on the biotechnology company’s stock. A number of other analysts have also recently issued reports on EVGN. StockNews.com began coverage on Evogene […]

Related Keywords

Roth Mkm ,Evogene Ltd ,Nasdaq ,Vident Investment Advisory ,Alliance Global Partners ,Virtu Financial ,Silverarc Capital Management ,Human Health ,Renaissance Technologies ,Free Report ,Street Capital ,Get Free Report ,Capital Management ,Investment Advisory ,Computational Predictive Biology ,Evogene Daily ,Evogene ,Nasdaq Evgn ,Devgn ,Medical ,Initiated Coverage ,